Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation

References

• Wang W, Roberts CJ. Aggregation of therapeutic proteins. New York: Wiley and Sons, 2010.
   Google Scholar
• Mahler HC, Friess W, Grauschopf U, Kiese S. Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 2009;98:2909–2934.
   PubMed Web of Science ®Google Scholar
• Arakawa T, Ejima D, Li T, Philo JS. The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals. J Pharm Sci 2010;99:1674–1692.
   PubMed Web of Science ®Google Scholar
• Zölls S, Tantipolphan R, Wiggenhorn M, Winter G, Jiskoot W, Friess W et al. Particles in therapeutic protein formulations, Part 1: overview of analytical methods. J Pharm Sci 2012;101:914–935.
   PubMed Web of Science ®Google Scholar
• Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJ, Middaugh CR, Winter G et al. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J Pharm Sci 2009;98:1201–1205.
   PubMed Web of Science ®Google Scholar
• Singh SK, Afonina N, Awwad M, Bechtold-Peters K, Blue JT, Chou D et al. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. J Pharm Sci 2010;99:3302–3321.
   PubMed Web of Science ®Google Scholar
• Narhi LO, Jiang Y, Cao S, Benedek K, Shnek D. A critical review of analytical methods for subvisible and visible particles. Curr Pharm Biotechnol 2009;10:373–381.
   PubMed Web of Science ®Google Scholar
• Sharma DK, Oma P, Pollo MJ, Sukumar M. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. J Pharm Sci 2009;98:2628–2642.
   Google Scholar
• Sharma DK, King D, Oma P, Merchant C. Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations. AAPS J 2010;12:455–464.
   PubMedGoogle Scholar
• Wuchner K, Büchler J, Spycher R, Dalmonte P, Volkin DB. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation. J Pharm Sci 2010;99:3343–3361.
   Google Scholar
• Huang CT, Sharma D, Oma P, Krishnamurthy R. Quantitation of protein particles in parenteral solutions using micro-flow imaging. J Pharm Sci 2009;98:3058–3071.
   PubMed Web of Science ®Google Scholar
• Chang LL, Shepherd D, Sun J, Ouellette D, Grant KL, Tang XC et al. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci 2005;94:1427–1444.
   PubMed Web of Science ®Google Scholar
• Chang LL, Shepherd D, Sun J, Tang XC, Pikal MJ. Effect of sorbitol and residual moisture on the stability of lyophilized antibodies: Implications for the mechanism of protein stabilization in the solid state. J Pharm Sci 2005;94:1445–1455.
   PubMed Web of Science ®Google Scholar
• Murphy BM, Zhang N, Payne RW, Davis JM, Abdul-Fattah AM, Matsuura JE, Herman AC, Manning MC. Structure, stability and mobility of a lyophilized IgG1 monoclonal antibody as determined using second derivative infrared spectroscopy. J Pharm Sci 2012;101: 81–91.
   PubMedGoogle Scholar
• Pikal MJ, Rigsbee D, Roy ML, Galreath D, Kovach KJ, Wang B et al. Solid state chemistry of proteins: II. The correlation of storage stability of freeze-dried human growth hormone (hGH) with structure and dynamics in the glassy solid. J Pharm Sci 2008;97:5106–5121.
   PubMed Web of Science ®Google Scholar
• Wang B, Cicerone MT, Aso Y, Pikal MJ. The impact of thermal treatment on the stability of freeze-dried amorphous pharmaceuticals: II. Aggregation in an IgG1 fusion protein. J Pharm Sci 2010;99:683–700.
   PubMedGoogle Scholar
• Pikal MJ, Chang LL, Tang XC. Evaluation of glassy-state dynamics from the width of the glass transition: results from theoretical simulation of differential scanning calorimetry and comparisons with experiment. J Pharm Sci 2004;93:981–994.
   PubMedGoogle Scholar
• Liu J, Rigsbee DR, Stotz C, Pikal MJ. Dynamics of amorphous pharmaceutical solids: the study of enthalpic relaxation by isothermal microcalorimetry. J Pharm Sci 2002;91:1853–1862.
   PubMed Web of Science ®Google Scholar
• Sane SU, Wong R, Hsu CC. Raman spectroscopic characterization of drying-induced structural changes in a therapeutic antibody: correlating structural changes with long-term stability. J Pharm Sci 2004;93:1005–1018.
   PubMed Web of Science ®Google Scholar
• Prestrelski SJ, Pikal KA, Arakawa T. Optimization of lyophilization conditions for recombinant human interleukin-2 by dried-state conformational analysis using Fourier-transform infrared spectroscopy. Pharm Res 1995;12:1250–1259.
   PubMed Web of Science ®Google Scholar
• Katayama DS, Kirchhoff CF, Elliott CM, Johnson RE, Borgmeyer J, Thiele BR et al. Retrospective statistical analysis of lyophilized protein formulations of progenipoietin using PLS: determination of the critical parameters for long-term storage stability. J Pharm Sci 2004;93:2609–2623.
   PubMedGoogle Scholar
• Meyer JD, Nayar R, Manning MC. Impact of bulking agents on the stability of a lyophilized monoclonal antibody. Eur J Pharm Sci 2009;38:29–38.
   PubMed Web of Science ®Google Scholar
• Carpenter JF, Prestrelski SJ, Dong A. Application of infrared spectroscopy to development of stable lyophilized protein formulations. Eur J Pharm Biopharm 1998;45:231–238.
   PubMed Web of Science ®Google Scholar
• Prestrelski SJ, Tedeschi N, Arakawa T, Carpenter JF. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys J 1993;65:661–671.
   PubMed Web of Science ®Google Scholar
• Chang BS, Beauvais RM, Dong A, Carpenter JF. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation. Arch Biochem Biophys 1996;331:249–258.
   PubMed Web of Science ®Google Scholar
• Chang BS, Reeder G, Carpenter JF. Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist. Pharm Res 1996;13:243–249.
   PubMed Web of Science ®Google Scholar
• Cleland JL, Lam X, Kendrick B, Yang J, Yang TH, Overcashier D et al. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci 2001;90:310–321.
   PubMed Web of Science ®Google Scholar
• Costantino HR, Langer R, Klibanov AM. Aggregation of a lyophilized pharmaceutical protein, recombinant human albumin: effect of moisture and stabilization by excipients. Biotechnology (NY) 1995;13:493–496.
   PubMedGoogle Scholar
• Shire SJ. Formulation and manufacturability of biologics. Curr Opin Biotechnol 2009;20:708–714.
   PubMed Web of Science ®Google Scholar
• Hawe A, Friess W, Sutter M, Jiskoot W. Online fluorescent dye detection method for the characterization of immunoglobulin G aggregation by size exclusion chromatography and asymmetrical flow field flow fractionation. Anal Biochem 2008;378:115–122.
   Google Scholar
• Philo JS. Is any measurement method optimal for all aggregate sizes and types? AAPS J 2006;8:E564–E571.
   PubMed Web of Science ®Google Scholar
• Litzén A, Walter JK, Krischollek H, Wahlund KG. Separation and quantitation of monoclonal antibody aggregates by asymmetrical flow field-flow fractionation and comparison to gel permeation chromatography. Anal Biochem 1993;212:469–480.
   PubMed Web of Science ®Google Scholar
• Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJ, Middaugh CR, Winter G. Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharm Sci 2010;99:2200–2208.
   PubMed Web of Science ®Google Scholar
• Poirier-Brulez F, Roudaut G, Champion D, Tanguy M, Simatos D. Influence of sucrose and water content on molecular mobility in starch-based glasses as assessed through structure and secondary relaxation. Biopolymers 2006;81:63–73.
   PubMedGoogle Scholar
• Abdul-Fattah AM, Truong-Le V, Yee L, Pan E, Ao Y, Kalonia DS et al. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine. Pharm Res 2007;24:715–727.
   PubMed Web of Science ®Google Scholar
• Cicerone MT, Douglas JF. β-relaxation governs protein stability in sugar-glass matrices. Soft Matter 2012;8:2983–2991.
   Google Scholar
• Cicerone MT, Soles CL, Chowdhuri Z, Pikal MJ, Chang L. Fast dynamics as a diagnostic for excipients in preservation of dried proteins. American Pharmaceutical Review 2005;8:22–27.
   Google Scholar
• Cicerone MT, Soles CL. Fast dynamics and stabilization of proteins: binary glasses of trehalose and glycerol. Biophys J 2004;86:3836–3845.
   PubMed Web of Science ®Google Scholar